Reporting Manager
Simeon George
Symbol
DSGN
Shares outstanding
61,756,000 shares
Disclosed Ownership
6,607,892 shares
Ownership
11%
Form type
SCHEDULE 13D/A
Filing time
11 Mar 2026, 21:28:31 UTC
Date of event
09 Mar 2026

Quoteable Key Fact

"SR One Capital Fund I Aggregator LP disclosed 11% ownership in Design Therapeutics, Inc. Common Stock, $0.0001 par value per share (DSGN) on 09 Mar 2026."

Quick Takeaways

  • SR One Capital Fund I Aggregator LP filed SCHEDULE 13D/A for Design Therapeutics, Inc. Common Stock, $0.0001 par value per share (DSGN).
  • Disclosed ownership: 11%.
  • Date of event: 09 Mar 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Mar 2026, 21:28.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SR One Capital Fund I Aggregator, LP 11% 6,526,476 0 6,526,476 /s/ Sasha Keough Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member 0001848319
SR One Capital Partners I, LP 11% 6,526,476 0 6,526,476 /s/ Sasha Keough Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
SR One Capital Management, LLC 11% 6,526,476 0 6,526,476 /s/ Sasha Keough Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
Simeon George 11% 6,607,892 81,416 6,526,476 /s/ Sasha Keough Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .